121 – 130 of 851
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
- Contribution to journal › Article
-
Mark
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
- Contribution to journal › Scientific review
-
Mark
Defining the Emerging Blood System During Development at Single-Cell Resolution
- Contribution to journal › Scientific review
-
Mark
Acute myeloid leukemia in patients we judge as being older and/or unfit
- Contribution to journal › Scientific review
-
Mark
Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
(2021) In International Journal of Laboratory Hematology
- Contribution to journal › Article
-
Mark
A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation
- Contribution to journal › Article
-
Mark
New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases
- Contribution to journal › Article
-
Mark
Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons
- Contribution to journal › Article
-
Mark
Impact of treatment delay in acute myeloid leukemia revisited
- Contribution to journal › Debate/Note/Editorial
-
Mark
Microglial activation elicits a negative affective state through prostaglandin-mediated modulation of striatal neurons
- Contribution to journal › Article
